Home
Conditions
Flaviviridae Infections

Clinical trial condition

Flaviviridae Infections

Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.

2,143 public trials 76 recruiting studies

Refine in advanced search Browse all conditions

Flaviviridae Infections trial results

Completed

A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C

NCT01194037

Conditions: Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +10 more
Locations: Los Angeles, California, United States

National City, California, United States

Miami, Florida, United States

Atlanta, Georgia, United States

View Trial Details

Completed

Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4)

NCT05268302

Conditions: Arbovirus Infections, Dengue, Flaviviridae Infections, +7 more
Locations: University of Maryland, Baltimore, Center for Vaccine Development and Global Health Baltimore, Maryland, United States

View Trial Details

Completed

Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)

NCT05123222

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +7 more
Locations: Johns Hopkins University, Bloomberg School of Public Health Baltimore, Maryland, United States

View Trial Details

Completed

Immunogenicity of Fractional One-fifth and One-half Doses of Yellow Fever Vaccine Compared to Full Dose in Children 9-23 Months Old

NCT03725618

Conditions: Arbovirus Infections, Flaviviridae Infections, Flavivirus Infections, +7 more
Locations: Centers for Disease Control and Prevention Atlanta, Georgia, United States

View Trial Details

Completed

Supporting Treatment Outcomes Among PWID

NCT04652804

Conditions: Behavior, Blood-Borne Infections, Communicable Diseases, +25 more
Locations: YR Gaitonde Centre for AIDS Research and Education Chennai, Tamil Nadu, India

View Trial Details

Completed

Hepatitis C Pharmacy-based Strategy for Injectors

NCT04698629

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations: University of Washington Seattle, Washington, United States

View Trial Details

Completed

Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

NCT04903626

Conditions: Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations: Arizona Health Research /ID# 233558 Chandler, Arizona, United States

The Institute for Liver Health /ID# 228427 Peoria, Arizona, United States

Liver Wellness Center /ID# 244933 Little Rock, Arkansas, United States

AHF Research Center /ID# 254795 Beverly Hills, California, United States

View all 70 locations

View Trial Details

Completed

Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis Care

NCT04178096

Conditions: Blood-Borne Infections, Cirrhosis, Liver, Communicable Diseases, +13 more
Locations: VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

Impacts of a Physical Therapy Protocol on Motor Function in Children With Congenital Zika Syndrome

NCT06900322

Conditions: Arbovirus Infections, Congenital Zika Syndrome, Flaviviridae Infections, +7 more
Locations: Instituto de Pesquisa Professor Joaquim Amorim Neto Campina Grande, Paraíba, Brazil

View Trial Details

Completed

HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function

NCT03902366

Conditions: Alcohol Use Disorder, Alcohol-Related Disorders, Alcoholism, +14 more
Locations: VA Portland Health Care System, Portland, OR Portland, Oregon, United States

View Trial Details

Flaviviridae Infections

Flaviviridae Infections trial results

Related conditions